Stereotactic Radiosurgery Safe for Koos Grade I Vestibular Schwannomas

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 20, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 19, 2024 -- Stereotactic radiosurgery (SRS) is safe and effective for management of Koos grade I vestibular schwannomas (VS) compared with observation, according to a study published online Nov. 6 in Neurosurgery.

Othman Bin-Alamer, M.B.B.S., from the University of Pittsburgh Medical Center, and colleagues evaluated the safety and efficacy of SRS versus observation for Koos grade I VS. The analysis included 142 patients.

During a median 36 months of follow-up, the researchers found that SRS significantly enhanced tumor control versus observation, with a 100 percent control rate at both five and eight years in the SRS group versus 48.6 and 29.5 percent in the observation group, respectively. At five and eight years, preservation of serviceable hearing outcomes between groups showed no significant differences (70.1 percent for SRS versus 53.4 percent for observation at five years). SRS was associated with a lower likelihood of tinnitus (odds ratio, 0.46), vestibular dysfunction (odds ratio, 0.17), and overall cranial nerve dysfunction (odds ratio, 0.49) at last follow-up.

"These findings support the safety and efficacy of SRS as a primary care approach for this patient population," the authors write. "Further prospective randomized studies are needed to validate these observations and delineate the superiority of SRS in this patient population."

Several authors disclosed ties to the biotechnology industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-21 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords